Dow Down2.14% Nasdaq Down3.17%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
3.26 Down 0.29(8.17%) 3:02PM EST - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 4,208   2,514   1,175   569  
Cost of Revenue3,676  757  528  341  
Gross Profit 532   1,757   647   228  
Operating Expenses
Research Development11,150  7,963  9,591  5,815  
Selling General and Administrative20,205  20,762  18,880  34,050  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (30,823) (26,968) (27,824) (39,637)
Income from Continuing Operations
Total Other Income/Expenses Net100  114  107  52  
Earnings Before Interest And Taxes(30,723)(26,854)(27,717)(39,585)
Interest Expense -   -   -   -  
Income Before Tax(30,723)(26,854)(27,717)(39,585)
Income Tax Expense22  23  22  700  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(30,745)(26,877)(27,739)(40,285)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (30,745) (26,877) (27,739) (40,285)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (30,745) (26,877) (27,739) (40,285)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.